Authors:
Rusnak, DW
Affleck, K
Cockerill, SG
Stubberfield, C
Harris, R
Page, M
Smith, KJ
Guntrip, SB
Carter, MC
Shaw, RJ
Jowett, A
Stables, J
Topley, P
Wood, ER
Brignola, PS
Kadwell, SH
Reep, BR
Mullin, RJ
Alligood, KJ
Keith, BR
Crosby, RM
Murray, DM
Knight, WB
Gilmer, TM
Lackey, K
Citation: Dw. Rusnak et al., The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancer, CANCER RES, 61(19), 2001, pp. 7196-7203
Authors:
Wolfe, LA
Mullin, RJ
Laethem, R
Blumenkopf, TA
Cory, M
Miller, JF
Keith, BR
Humphreys, J
Smith, GK
Citation: La. Wolfe et al., Antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1: In vitro and in vivo studies with prodrugs of methotrexate and the thymidylate synthase inhibitors GW1031 and GW1843, BIOCONJ CHE, 10(1), 1999, pp. 38-48